Combined association of key risk factors on ischaemic outcomes and bleeding in patients with myocardial infarction

被引:22
作者
Lindholm, Daniel [1 ]
Sarno, Giovanna [2 ]
Erlinge, David [3 ]
Svennblad, Bodil [4 ]
Hasvold, Lars Pal [5 ]
Janzon, Magnus [6 ]
Jernberg, Tomas [7 ]
James, Stefan K. [4 ]
机构
[1] AstraZeneca R&D, Gothenburg, Sweden
[2] Uppsala Univ, Dept Med Sci, Cardiol, Uppsala, Sweden
[3] Lund Univ, Dept Cardiol, Lund, Sweden
[4] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden
[5] AstraZeneca, Dept Med, Sodertalje, Sweden
[6] Linkoping Univ, Dept Med & Hlth Sci, Dept Cardiol, Linkoping, Sweden
[7] Karolinska Inst, Danderyd Univ Hosp, Dept Clin Sci, Stockholm, Sweden
关键词
risk factors; acute coronary syndromes; DUAL ANTIPLATELET THERAPY; TICAGRELOR; CLOPIDOGREL; VALIDATION; DISEASE; EVENTS;
D O I
10.1136/heartjnl-2018-314590
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective In patients with myocardial infarction (MI), risk factors for bleeding and ischaemic events tend to overlap, but the combined effects of these factors have scarcely been studied in contemporary real-world settings. We aimed to assess the combined associations of established risk factors using nationwide registries. Methods Using the Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies registry, patients with invasively managed MI in 2006-2014 were included. Six factors were assessed in relation to cardiovascular death (CVD)/MI/stroke, and major bleeding: age >= 65, chronic kidney disease, diabetes, multivessel disease, prior bleeding and prior MI. Results We studied 100 879 patients, of whom 20 831 (20.6%) experienced CVD/MI/stroke and 5939 (5.9%) major bleeding, during 3.6 years median follow-up. In adjusted Cox models, all factors were associated with CVD/MI/stroke, and all but prior MI were associated with major bleeding. The majority (53.5%) had >= 2 risk factors. With each added risk factor, there was a marked but gradual increase in incidence of the CVD/MI/stroke. This was seen also for major bleeding, but to a lesser extent, largely driven by prior bleeding as the strongest risk factor. Conclusions The majority of patients with MI had two or more established risk factors. Increasing number of risk factors was associated with higher rate of ischaemic events. When excluding patients with prior major bleeding, bleeding incidence rate increased only minimally with increasing number of risk factors. The high ischaemic risk in those with multiple risk factors highlights an unmet need for additional preventive measures.
引用
收藏
页码:1175 / 1181
页数:7
相关论文
共 19 条
[1]   Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables [J].
Ahlqvist, Emma ;
Storm, Petter ;
Karajamaki, Annemari ;
Martinell, Mats ;
Dorkhan, Mozhgan ;
Carlsson, Annelie ;
Vikman, Petter ;
Prasad, Rashmi B. ;
Aly, Dina Mansour ;
Almgren, Peter ;
Wessman, Ylva ;
Shaat, Nael ;
Spegel, Peter ;
Mulder, Hindrik ;
Lindholm, Eero ;
Melander, Olle ;
Hansson, Ola ;
Malmqvist, Ulf ;
Lernmark, Ake ;
Lahti, Kaj ;
Forsen, Tom ;
Tuomi, Tiinamaija ;
Rosengren, Anders H. ;
Groop, Leif .
LANCET DIABETES & ENDOCRINOLOGY, 2018, 6 (05) :361-369
[2]   Risk factors for myocardial infarction in women and men: insights from the INTERHEART study [J].
Anand, Sonia S. ;
Islam, Shofiqul ;
Rosengren, Annika ;
Franzosi, Maria Grazia ;
Steyn, Krisela ;
Yusufali, Afzal Hussein ;
Keltai, Matyas ;
Diaz, Rafael ;
Rangarajan, Sumathy ;
Yusuf, Salim .
EUROPEAN HEART JOURNAL, 2008, 29 (07) :932-940
[3]   Ticagrelor for Secondary Prevention of Atherothrombotic Events in Patients With Multivessel Coronary Disease [J].
Bansilal, Sameer ;
Bonaca, Marc P. ;
Cornel, Jan H. ;
Storey, Robert F. ;
Bhatt, Deepak L. ;
Steg, Gabriel ;
Im, Kyungah ;
Murphy, Sabina A. ;
Angiolillo, Dominick J. ;
Kiss, Robert G. ;
Parkhomenko, Alexander N. ;
Lopez-Sendon, Jose ;
Isaza, Daniel ;
Goudev, Assen ;
Kontny, Frederic ;
Held, Peter ;
Jensen, Eva C. ;
Braunwald, Eugene ;
Sabatine, Marc S. ;
Ophuis, A. J. Oude .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (05) :489-496
[4]   Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction [J].
Bonaca, Marc P. ;
Bhatt, Deepak L. ;
Cohen, Marc ;
Steg, Philippe Gabriel ;
Storey, Robert F. ;
Jensen, Eva C. ;
Magnani, Giulia ;
Bansilal, Sameer ;
Fish, M. Polly ;
Im, Kyungah ;
Bengtsson, Olof ;
Ophuis, Ton Oude ;
Budaj, Andrzej ;
Theroux, Pierre ;
Ruda, Mikhail ;
Hamm, Christian ;
Goto, Shinya ;
Spinar, Jindrich ;
Nicolau, Jose Carlos ;
Kiss, Robert G. ;
Murphy, Sabina A. ;
Wiviott, Stephen D. ;
Held, Peter ;
Braunwald, Eugene ;
Sabatine, Marc S. ;
Morin, Suzanne ;
Dantzer, Emily ;
Acquilano, Dayle ;
McGuire, Rachael L. ;
Gannon, Joseph B. ;
Gershman, Elaine ;
Ahlbom, Ann Maxe ;
Boberg, Barbro ;
Abola, Maria Teresa ;
Ardissino, Diego ;
Aylward, Philip ;
Corbalan, Ramon ;
Dalby, Anthony ;
Diaz, Rafael ;
Hu, Dayi ;
Isaza, Daniel ;
Kamensky, Gabriel ;
Kiss, Robert ;
Kontny, Frederic ;
Lopez-Sendon, Jose ;
Medina, Felix ;
Montalescot, Gilles ;
Nicolau, Jose ;
Paolasso, Ernesto ;
Parkhomenko, Alexander .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (19) :1791-1800
[5]   Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials [J].
Costa, Francesco ;
van Klaveren, David ;
James, Stefan ;
Heg, Dik ;
Raber, Lorenz ;
Feres, Fausto ;
Pilgrim, Thomas ;
Hong, Myeong-Ki ;
Kim, Hyo-Soo ;
Colombo, Antonio ;
Steg, Philippe Gabriel ;
Zanchin, Thomas ;
Palmerini, Tullio ;
Wallentin, Lars ;
Bhatt, Deepak L. ;
Stone, Gregg W. ;
Windecker, Stephan ;
Steyerberg, Ewout W. ;
Valgimigli, Marco .
LANCET, 2017, 389 (10073) :1025-1034
[6]   Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease [J].
Eikelboom, J. W. ;
Connolly, S. J. ;
Bosch, J. ;
Dagenais, G. R. ;
Hart, R. G. ;
Shestakovska, O. ;
Diaz, R. ;
Alings, M. ;
Lonn, E. M. ;
Anand, S. S. ;
Widimsky, P. ;
Hori, M. ;
Avezum, A. ;
Piegas, L. S. ;
Branch, K. R. H. ;
Probstfield, J. ;
Bhatt, D. L. ;
Zhu, J. ;
Liang, Y. ;
Maggioni, A. P. ;
Lopez-Jaramillo, P. ;
O'Donnell, M. ;
Kakkar, A. K. ;
Fox, K. A. A. ;
Parkhomenko, A. N. ;
Ertl, G. ;
Stoerk, S. ;
Keltai, M. ;
Ryden, L. ;
Pogosova, N. ;
Dans, A. L. ;
Lanas, F. ;
Commerford, P. J. ;
Torp-Pedersen, C. ;
Guzik, T. J. ;
Verhamme, P. B. ;
Vinereanu, D. ;
Kim, J. -H. ;
Tonkin, A. M. ;
Lewis, B. S. ;
Felix, C. ;
Yusoff, K. ;
Steg, P. G. ;
Metsarinne, K. P. ;
Bruns, N. Cook ;
Misselwitz, F. ;
Chen, E. ;
Leong, D. ;
Yusuf, S. ;
Aboyans, V. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (14) :1319-1330
[7]   Usefulness of Health Registers for detection of bleeding events in outcome studies [J].
Friberg, Leif ;
Skeppholm, Mika .
THROMBOSIS AND HAEMOSTASIS, 2016, 116 (06) :1131-1139
[8]   Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention [J].
Gansevoort, Ron T. ;
Correa-Rotter, Ricardo ;
Hemmelgarn, Brenda R. ;
Jafar, Tazeen H. ;
Heerspink, Hiddo J. Lambers ;
Mann, Johannes F. ;
Matsushita, Kunihiro ;
Wen, Chi Pang .
LANCET, 2013, 382 (9889) :339-352
[9]   The Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART) [J].
Jernberg, Tomas ;
Attebring, Mona F. ;
Hambraeus, Kristina ;
Ivert, Torbjorn ;
James, Stefan ;
Jeppsson, Anders ;
Lagerqvist, Bo ;
Lindahl, Bertil ;
Stenestrand, Ulf ;
Wallentin, Lars .
HEART, 2010, 96 (20) :1617-1621
[10]   Growth Differentiation Factor 15 at 1 Month After an Acute Coronary Syndrome Is Associated With Increased Risk of Major Bleeding [J].
Lindholm, Daniel ;
Hagstrom, Emil ;
James, Stefan K. ;
Becker, Richard C. ;
Cannon, Christopher P. ;
Himmelmann, Anders ;
Katus, Hugo A. ;
Maurer, Gerald ;
Luis Lopez-Sendon, Jose ;
Steg, Philippe Gabriel ;
Storey, Robert F. ;
Siegbahn, Agneta ;
Wallentin, Lars .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (04)